Results for tag: "Internal Neuromodulation Devices"

Internal neuromodulation devices are a subset of medical devices used in various surgical procedures aimed at altering nerve activity by delivering electrical or pharmacological agents directly to a target area. These devices are employed in the treatment of chronic pain, movement disorders, spasticity, and other conditions that affect nervous system functioning. The surgical procedures involving internal neuromodulation devices can be broadly categorized into implantation and stimulation techniques. Implantation involves the surgical insertion of devices such as spinal cord stimulators, deep brain stimulators, or sacral nerve stimulators. These procedures often require precise placement and are typically conducted by neurosurgeons or specialist surgeons with expertise in the nervous system. Once implanted, these devices modulate neural activity through programmable electrical impulses, aiming to restore certain physiological functions or relieve symptoms. The critical elements of internal neuromodulation encompass device design, surgical techniques, patient-specific customization, and postoperative management. These devices represent a specialized intersection between technology, surgery, and neurology, reflecting a multifaceted approach to treat complex conditions that are resistant to more conventional therapies. Several influential companies operational in the internal neuromodulation devices market include Medtronic, Boston Scientific Corporation, and Abbott Laboratories. These enterprises research, develop, and manufacture a diverse array of neuromodulation devices and continue to innovate in the field with advancements in technology and surgical applications. Other notable players such as Nevro Corp and LivaNova PLC contribute to the dynamic landscape of the industry, enhancing Show Less Read more